High Quality Proteins with Multiple Post Translational Modifications

具有多种翻译后修饰的高质量蛋白质

基本信息

项目摘要

High Quality Proteins with Multiple Post Translational Modifications Foundation for Applied Molecular Evolution Shuichi Hoshika ABSTRACT The proposed technology will make, by in vitro translation (IVT), proteins that hold non-canonical amino acids normally put in only by post-translational modification (PTM). The immediate deliverable will be tech- nology that delivers proteins with three PTM-AAs (acetyllysine, phosphserine, phosphotyrosine) incorporated in many, exact positions in long (300 - 1100 amino acid proteins are used) proteins with >95% occupancy. The NCI itself motivated this proposal by its calls for tools to make such proteins, which cancer researchers need throughout cancer proteomics. Today, such proteins are available only via isolation from living eukaryotic cells. These are rarely pure. Our pure PTM proteins will be used to get antibodies, identify PTM signatures of cancers, standardize quantitative immunoassays as standards, discover inhibitors and drugs for cancer-related enzymes in their drug-relevant forms, and study protein-protein interactions. These will be obtained rapidly and inexpensively in their own labs (with in vitro translation kits) or via service companies (as for antibodies). As Performance Measures, the NCI defined "useable amounts" to be "0.5 to 1 mg of protein" with "50- 80% modification at the specified site". Our technology will do better, generating 1-10 mg of protein with >95% modification for three different PTM amino acids at many specified sites. Behind this project is an ongoing revolution in the synthetic biology of DNA and RNA (xNA) that delivered expanded xNA, enhanced in 2019 by the PI. Artificial xNA looks like standard xNA. However, it adds pairs by shuffling hydrogen bonding groups, allowing expanded xNA to “write” more AA “words” in a protein “lexicon”. Consistent with an IMAT R21 format, this project will prove concepts, de-risk procedures, and take enough steps to guide the NCI as it seeks to complete this transformative technology. We will use only 8 "hachimoji" nucleotides to systematically add, in three Aims, these PTM-AAs while developing the concepts to control the interactions that must be controlled to meet this grand challenge: (i) between hachimoji codons and anticodons during translation, (ii) between synthetases and hachimoji anticodons during aminoacylation, and (iii) between orthogonal hachimoji charged tRNAs and parts of the E. coli ribosome complex. Even with this limited scope, the technology will be transformative because of the importance of these PTM-AAs. As Aims are met, our ability to meet Performance Measures will be shown by making Prohibitin 2 (7 exemplars of these 3 PTM-AAs) using enhanced IVT (eIVT) . As a long term deliverable, since 8-letter DNA can deliver 512 codons, all PTM AAs can be incorporated into proteins using this technology, a more transformative outcome. Next, as researchers advance IVT and move hachimoji DNA into living cells, even more transformative outcomes are possible in a long term vision.
具有多个翻译后修饰的高质量蛋白质

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shuichi Hoshika其他文献

Shuichi Hoshika的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shuichi Hoshika', 18)}}的其他基金

High Quality Proteins with Multiple Post Translational Modifications
具有多种翻译后修饰的高质量蛋白质
  • 批准号:
    10271814
  • 财政年份:
    2021
  • 资助金额:
    $ 15.37万
  • 项目类别:

相似海外基金

Elucidation of aging phenomenom based on the assessment of tRNA aminoacylation.
基于 tRNA 氨酰化评估阐明衰老现象。
  • 批准号:
    22K19414
  • 财政年份:
    2022
  • 资助金额:
    $ 15.37万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Elucidating the Functional Role of Post-translational Aminoacylation in Chromatin Regulation
阐明翻译后氨酰化在染色质调节中的功能作用
  • 批准号:
    10489710
  • 财政年份:
    2022
  • 资助金额:
    $ 15.37万
  • 项目类别:
Mechanism of Chiral-Selective Aminoacylation of a Primordial RNA Minihelix Studied by Quantum Chemical Calculations
通过量子化学计算研究原始 RNA 微螺旋的手性选择性氨酰化机制
  • 批准号:
    20K06592
  • 财政年份:
    2020
  • 资助金额:
    $ 15.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
In vitro evolution of a peptide-ribozyme complex catalyzing aminoacylation
催化氨酰化的肽-核酶复合物的体外进化
  • 批准号:
    19K16200
  • 财政年份:
    2019
  • 资助金额:
    $ 15.37万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Protein/tRNA and conformational changes involved in the faithful aminoacylation of tRNAs specific for glutamate, glutamine, aspartate and aspargine
谷氨酸、谷氨酰胺、天冬氨酸和天冬酰胺特异性 tRNA 的忠实氨酰化涉及的蛋白质/tRNA 和构象变化
  • 批准号:
    9597-2010
  • 财政年份:
    2014
  • 资助金额:
    $ 15.37万
  • 项目类别:
    Discovery Grants Program - Individual
Biomimetic direct aminoacylation of tRNA
tRNA 的仿生直接氨酰化
  • 批准号:
    425730-2012
  • 财政年份:
    2013
  • 资助金额:
    $ 15.37万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Protein/tRNA and conformational changes involved in the faithful aminoacylation of tRNAs specific for glutamate, glutamine, aspartate and aspargine
谷氨酸、谷氨酰胺、天冬氨酸和天冬酰胺特异性 tRNA 的忠实氨酰化涉及的蛋白质/tRNA 和构象变化
  • 批准号:
    9597-2010
  • 财政年份:
    2013
  • 资助金额:
    $ 15.37万
  • 项目类别:
    Discovery Grants Program - Individual
Protein/tRNA and conformational changes involved in the faithful aminoacylation of tRNAs specific for glutamate, glutamine, aspartate and aspargine
谷氨酸、谷氨酰胺、天冬氨酸和天冬酰胺特异性 tRNA 的忠实氨酰化涉及的蛋白质/tRNA 和构象变化
  • 批准号:
    9597-2010
  • 财政年份:
    2012
  • 资助金额:
    $ 15.37万
  • 项目类别:
    Discovery Grants Program - Individual
Biomimetic direct aminoacylation of tRNA
tRNA 的仿生直接氨酰化
  • 批准号:
    425730-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 15.37万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Protein/tRNA and conformational changes involved in the faithful aminoacylation of tRNAs specific for glutamate, glutamine, aspartate and aspargine
谷氨酸、谷氨酰胺、天冬氨酸和天冬酰胺特异性 tRNA 的忠实氨酰化涉及的蛋白质/tRNA 和构象变化
  • 批准号:
    9597-2010
  • 财政年份:
    2011
  • 资助金额:
    $ 15.37万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了